PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis

Table 1

Statistical analysis of the treatment effect of the two groups of patients (, %).

Group	Number ()	Effectivity	Improvement	Nullity	Total effectiveness
Observation group	30	3 (10.00)	25 (83.33)	2 (6.67)	28 (93.33)
Control group	30	1 (3.33)	21 (70.00)	8 (26.67)	22 (73.33)
value					4.32
value					0.037

: the difference between the groups was statistically significant.